Xingbo D. Long

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials.

Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials.

Journal: Prostate cancer and prostatic diseases

Published: November 26, 2025

A novel mouse model for LAMA2-related muscular dystrophy with analysis of molecular pathogenesis and clinical phenotype.

A novel mouse model for LAMA2-related muscular dystrophy with analysis of molecular pathogenesis and clinical phenotype.

Journal: eLife

Published: September 17, 2025

Stromal SRD5A2 promotes prostate growth through WNT5A-LEF1-IGF1 signaling in benign prostatic hyperplasia.

Stromal SRD5A2 promotes prostate growth through WNT5A-LEF1-IGF1 signaling in benign prostatic hyperplasia.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A-Lymphoid Enhancer-Binding Factor 1-Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia.

Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A-Lymphoid Enhancer-Binding Factor 1-Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia.

Journal: The American journal of pathology

Published: June 03, 2025

Stromal reprogramming in urachal cancer: Fibroblast activation protein and collagen remodeling drive immune-suppressive niches and immunotherapy resistance.

Stromal reprogramming in urachal cancer: Fibroblast activation protein and collagen remodeling drive immune-suppressive niches and immunotherapy resistance.

Journal: International immunopharmacology

Published: April 24, 2025

BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities.

BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities.

Journal: European journal of medical research

Published: April 19, 2025

Risk of seizure in patients with prostate cancer treated with enzalutamide in China: a noninterventional study.

Risk of seizure in patients with prostate cancer treated with enzalutamide in China: a noninterventional study.

Journal: Therapeutic advances in drug safety

Published: March 25, 2025

Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2.

Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2.

Journal: The Journal of pathology

Published: December 15, 2023

Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling.

Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling.

Journal: Cancer research

Published: January 30, 2023

C1q/TNF-related protein 4 mediates proliferation and migration of vascular smooth muscle cells during vascular remodelling.

C1q/TNF-related protein 4 mediates proliferation and migration of vascular smooth muscle cells during vascular remodelling.

Journal: Clinical and translational medicine

Published: January 16, 2023

Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer.

Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer.

Journal: International journal of molecular sciences

Published: September 28, 2022

Single-cell RNA-sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone.

Single-cell RNA-sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone.

Journal: Clinical and translational medicine

Published: July 03, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026